What is the current estimated cost to the NHS due to MRSA related infections?
Estimated costs to the NHS of hospital acquired infections run at approximately £1 billion. In the USA in 1999, MRSA treatment costs were estimated to be 6-10% more than treating an MSSA infection (resulting from the increased cost of vancomycin use and costly isolation procedures), and that the attributable death rate of MRSA was 21% as compared to 8% in MSSA.
